Literature DB >> 23809358

Impact of renal dysfunction in cirrhotic patients with bacterial infections other than spontaneous bacterial peritonitis.

Tsung-Hsing Hung1, Chu-Lin Chou, Te-Chao Fang.   

Abstract

AIM: The impact of renal dysfunction has not been well evaluated among cirrhotic patients having bacterial infections other than spontaneous bacterial peritonitis (SBP). We aimed to examine the impact of renal function impairment (RFI) among cirrhotic patients with non-SBP bacterial infections.
METHODS: Data of 7134 cirrhotic patients with non-SBP bacterial infections extracted from the Taiwan National Health Insurance Database, derived from the Taiwan National Health Insurance Program, in 2004 were analyzed.
RESULTS: A total of 579 (8.1%) patients had renal dysfunction. Of these, 223 patients had acute renal failure (ARF), and 141 had end-stage renal disease (ESRD) requiring hemodialysis before admission. The overall 30-day, 1-year and 3-year mortalities were 15.8%, 39.3% and 54.5%, respectively. Compared with the non-RFI group, the adjusted hazard ratios (HR) of 30-day mortality for RFI, ARF and ESRD were 3.20 (P < 0.001), 4.81 (P < 0.001) and 1.59 (P = 0.015); the adjusted HR of 1-year mortality for RFI, ARF and ESRD were 2.68 (P < 0.001), 3.50 (P < 0.001) and 1.84 (P < 0.001), and adjusted HR of 3-year mortality for RFI, ARF and ESRD were 2.34 (P < 0.001), 2.97 (P < 0.001) and 1.76 (P < 0.001). The adjusted HR of 30-day, 1-year and 3-year mortalities for the ARF group were 2.98 (P < 0.001), 1.74 (P < 0.001) and 1.58 (P = 0.001) compared with the ESRD group, respectively.
CONCLUSION: This population-based cohort study shows that RFI, especially ARF, is an independent poor prognostic factor in cirrhotic patients with non-SBP bacterial infections.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  acute renal failure; bacterial infections; cirrhosis; end-stage renal disease; renal dysfunction

Year:  2013        PMID: 23809358     DOI: 10.1111/hepr.12190

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study.

Authors:  Chu-Lin Chou; Shu-Hui Juan; Ching-Hao Li; Hsi-Hsien Chen; Chih-Chin Kao; Li-Ying Chen; Li-Nien Chien; Te-Chao Fang
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

2.  Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study.

Authors:  Chiu-Huang Kuo; Tsung-Cheng Hsieh; Chih-Hsien Wang; Chu-Lin Chou; Yu-Hsien Lai; Yi-Ya Chen; Yu-Li Lin; Sheng-Teng Wu; Te-Chao Fang
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

3.  Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case-Control Study.

Authors:  Li-Nien Chien; Chu-Lin Chou; His-Hsien Chen; Chih-Chin Kao; Yen-Chung Lin; Yueh-Lin Wu; Jin-Shuen Chen; Li-Ying Chen; Te-Chao Fang
Journal:  J Am Heart Assoc       Date:  2017-11-16       Impact factor: 5.501

4.  Risks of all-cause mortality and major kidney events in patients with new-onset primary open-angle glaucoma: a nationwide long-term cohort study in Taiwan.

Authors:  Chu-Lin Chou; Tsung-Cheng Hsieh; Jin-Shuen Chen; Te-Chao Fang
Journal:  BMJ Open       Date:  2018-03-22       Impact factor: 2.692

5.  Continuous veno-venous hemofiltration yields better renal outcomes than intermittent hemodialysis among traumatic intracranial hemorrhage patients with acute kidney injury: A nationwide population-based retrospective study in Taiwan.

Authors:  Min-Feng Tseng; Chu-Lin Chou; Chi-Hsiang Chung; Wu-Chien Chien; Ying-Kai Chen; Hsiu-Chien Yang; Chen-Yi Liao; Kuang-Yu Wei; Chia-Chao Wu
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

6.  Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.

Authors:  Yi-Chun Wang; Tsung-Cheng Hsieh; Chu-Lin Chou; Jung-Lun Wu; Te-Chao Fang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.